Avid Bioservices Inc Quick Ratio (CDMO) starting from the second quarter 2024 to second quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Avid Bioservices Inc   (NASDAQ: CDMO)

Avid Bioservices Inc 's Quick Ratio

CDMO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2024, Quick Ratio fell to 0.45 below Avid Bioservices Inc average.

Within Major Pharmaceutical Preparations industry 409 other companies have achieved higher Quick Ratio than Avid Bioservices Inc in second quarter 2024. While Quick Ratio total ranking in the second quarter 2024 has deteriorated compared to the prior quarter from 1649 to 2511.

Explain Quick Ratio?
How much Cash & cash equivalents CDMO´s has?
What are CDMO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CDMO Quick Ratio (Oct 31 2024)
Q2		 (Jul 31 2024)
Q1		 (Apr 30 2024)
Q4		 (Jan 31 2024)
Q3		 (Oct 31 2023)
Q2
Y / Y Current Liabilities Change -66.18 % -65.48 % -67.72 % 155.26 % 166.19 %
Y / Y Cash & cash equivalent Change 6.34 % 34.07 % -1.13 % -48.75 % -59.34 %
Quick Ratio MRQ 0.45 0.47 0.54 0.14 0.14
CDMO's Total Ranking # 2511 # 1649 # 1624 # 4108 # 2450
Seq. Current Liabilities Change 4.32 % 0.73 % -68.34 % 1.65 % 6.47 %
Seq. Cash & cash equivalent Change 0.1 % -12.4 % 24.09 % -2.28 % 26.21 %



Quick Ratio second quarter 2024 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 410
Healthcare Sector # 778
Overall Market # 2511


Quick Ratio Statistics
High Average Low
5.54 1.56 0.12
(Oct 31 2018)   (Jul 31 2023)




Financial Statements
Avid Bioservices Inc 's Current Liabilities $ 74 Millions Visit CDMO's Balance sheet
Avid Bioservices Inc 's Cash & cash equivalent $ 33 Millions Visit CDMO's Balance sheet
Source of CDMO's Sales Visit CDMO's Sales by Geography


Cumulative Avid Bioservices Inc 's Quick Ratio

CDMO's Quick Ratio for the trailling 12 Months

CDMO Quick Ratio

 (Oct 31 2024)
12 Months		 (Jul 31 2024)
12 Months		 (Apr 30 2024)
12 Months		 (Jan 31 2024)
12 Months		 (Oct 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth -40 % -1.75 % 49.22 % 155.81 % 122.37 %
Y / Y Cash & cash equivalent TTM Growth -12.39 % -33.41 % -56.98 % -66.82 % -66.97 %
Quick Ratio TTM 0.31 0.23 0.17 0.14 0.21
Total Ranking TTM # 3581 # 2679 # 1356 # 4181 # 3371
Seq. Current Liabilities TTM Growth -24.86 % -18.77 % -17.08 % 18.54 % 23.04 %
Seq. Cash & cash equivalent TTM Growth 1.49 % 6.78 % -0.35 % -18.87 % -22.86 %

Quick ratio ranking by company, industry and sector >> Back to CDMO Financial Strength Comparisons >> Go to Compare CDMO Quick Ratio to its Competitors

On the trailing twelve months basis CDMO Cash & cash equivalent improved by 6.34 % in Q2 2024 year on year, while Current Liabilities rose to $74 millions, this led to increase in in Avid Bioservices Inc 's Quick Ratio to 0.31, Quick Ratio remained below CDMO average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 451 other companies have achieved higher Quick Ratio than Avid Bioservices Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2024 from 2679 to 3581.

Explain Quick Ratio?
How much Cash & cash equivalents CDMO´s has?
What are CDMO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 452
Healthcare Sector # 953
Within the Market # 3581


trailing twelve months Quick Ratio Statistics
High Average Low
3.25 1.29 0.15
(Sep. 30, 2014)   (Jan 31 2024)




Companies with similar Quick Ratio in the quarter ending Oct 31 2024, within Major Pharmaceutical Preparations Industry Quick RatioOct 31 2024 MRQ Cash & cash equivalentOct 31 2024 MRQ Current Liabilities
Organogenesis Holdings Inc   1.22 $ 94.340  Millions$ 77.281  Millions
Zomedica Corp   1.21 $ 9.747  Millions$ 8.064  Millions
Fibrobiologics Inc   1.17 $ 7.827  Millions$ 6.677  Millions
Nature s Sunshine Products inc   1.17 $ 78.704  Millions$ 67.150  Millions
Innoviva Inc   1.16 $ 260.630  Millions$ 223.750  Millions
Briacell Therapeutics Corp   1.16 $ 5.792  Millions$ 4.989  Millions
Evoke Pharma Inc   1.16 $ 11.339  Millions$ 9.766  Millions
Mersana Therapeutics inc   1.15 $ 78.868  Millions$ 68.301  Millions
Nurix Therapeutics Inc   1.15 $ 99.044  Millions$ 86.296  Millions
Perrigo Company Plc  1.14 $ 1,463.500  Millions$ 1,282.200  Millions
Arcutis Biotherapeutics Inc   1.14 $ 195.710  Millions$ 172.426  Millions
Rigel Pharmaceuticals Inc  1.13 $ 61.114  Millions$ 54.312  Millions
Bgm Group Ltd  1.12 $ 9.817  Millions$ 8.776  Millions
Entrada Therapeutics Inc   1.11 $ 78.049  Millions$ 70.603  Millions
Verrica Pharmaceuticals Inc   1.09 $ 22.959  Millions$ 21.026  Millions
Seres Therapeutics Inc   1.03 $ 66.824  Millions$ 64.833  Millions
Eton Pharmaceuticals Inc   1.03 $ 20.261  Millions$ 19.734  Millions
Clearmind Medicine Inc  1.01 $ 4.716  Millions$ 4.657  Millions
Evotec Se  1.01 $ 390.058  Millions$ 385.935  Millions
Zoetis Inc   1.01 $ 1,714.000  Millions$ 1,702.000  Millions
Applied Therapeutics Inc   1.00 $ 98.867  Millions$ 98.967  Millions
Cytomx Therapeutics Inc   0.99 $ 117.588  Millions$ 119.228  Millions
Earth Science Tech Inc   0.98 $ 1.555  Millions$ 1.581  Millions
Assertio Holdings inc   0.98 $ 88.579  Millions$ 90.104  Millions
Phibro Animal Health Corporation  0.96 $ 89.837  Millions$ 94.028  Millions
Transcode Therapeutics Inc   0.93 $ 1.988  Millions$ 2.131  Millions
Royalty Pharma Plc  0.92 $ 998.552  Millions$ 1,088.609  Millions
Abbott Laboratories  0.91 $ 7,788.000  Millions$ 8,519.000  Millions
Corvus Pharmaceuticals Inc   0.90 $ 41.651  Millions$ 46.406  Millions
Puma Biotechnology Inc   0.88 $ 96.725  Millions$ 110.397  Millions

Date modified: 2026-09-08T15:11:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.